{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:15:37Z","timestamp":1791825337682,"version":"4.3.4"},"reference-count":0,"publisher":"Wiley","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.clpt.2003.09.001","type":"journal-article","created":{"date-parts":[[2003,12,5]],"date-time":"2003-12-05T11:41:56Z","timestamp":1070624516000},"page":"581-590","source":"Crossref","is-referenced-by-count":15,"title":["Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome"],"prefix":"10.1111","volume":"74","author":[{"given":"T","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","container-title":["Clinical Pharmacology & Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:16:39Z","timestamp":1699362999000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1016\/j.clpt.2003.09.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0009-9236(03)00286-8"],"URL":"https:\/\/doi.org\/10.1016\/j.clpt.2003.09.001","relation":{},"ISSN":["0009-9236"],"issn-type":[{"value":"0009-9236","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}